SEBI禁止来自市场的Nirman Agri遗传学公司滥用国际采购组织93%的资金,暂停关键计划和交易。 SEBI bars Nirman Agri Genetics from markets over misuse of 93% of IPO funds, suspends key plans and trading.

Nirman Agri遗传有限公司股份在2025年10月15日下跌5%,因为SEBI禁止该公司进入证券市场,指控该公司滥用其IPO资金的近93%(约18.89卢比),将这些资金转用于与Pranav Kailas Bagal推销商及其亲属有联系的可疑或假实体。 Shares of Nirman Agri Genetics Limited fell 5% on October 15, 2025, after SEBI barred the company from the securities market over allegations of misusing nearly 93% of its IPO funds—about Rs 18.89 crore—by diverting them to suspicious or fake entities linked to promoter Pranav Kailas Bagal and his relatives. SEBI没有发现向4个供应商付款的有效发票或协议,现场检查证实所列供应商的地址无法运作。 SEBI found no valid invoices or agreements for payments to four vendors, and site inspections confirmed the listed vendor addresses were non-operational. 监管机构中止了计划中的公司行动,包括奖金和名称变更,并禁止Bagal进行股票交易。 The regulator suspended planned corporate actions, including a bonus issue and name change, and banned Bagal from trading the stock. 在进一步调查之前,这些限制仍然有效。 The restrictions remain in place pending further investigation.